Novo Nordisk A/S (NVO)
Current
- (-)
After Hours
Rating Performance
Rating Return
+0.0% vs
Rating Accuracy
0.0% (0 of 0*)
Rating Return
+0.0% vs
Rating Accuracy
0.0% (0 of 0*)
Rating Return
+0.0% vs
Rating Accuracy
0.0% (0 of 0*)
Rating Return
+0.0% vs
Rating Accuracy
0.0% (0 of 0*)
FV Performance
FV Accuracy
0 Hits (0.0% Hit Rate)
FV Avg. Distance
+0.0%
FV Accuracy
0 Hits (0.0% Hit Rate)
FV Avg. Distance
-14.93%
FV Accuracy
0 Hits (0.0% Hit Rate)
FV Avg. Distance
-17.12%
FV Accuracy
2 Hits (4.08% Hit Rate)
FV Avg. Distance
-11.96%
About
CEO
Lars Fruergaard Jørgensen
Employees
43,258
Industry
-
Sector
-
Headquarters
Bagsværd
Exchange
New York Stock Exchange
Website
http://www.novonordisk.comSummary Stats
Market Cap
192B
Revenue
-
Net Income
-
EPS
$0.00
Price-to-Earnings
-
Price-to-Book
-
Debt-to-Equity
-
News
Analyst Ratings
Price targets projected by 23 analysts
High
$86.00
Average
$72.51
Low
$52.00
Ratings calculated by 27 analysts
Buy
14
Hold
9
Sell
4
Last Dividend
Amount
-
Dividend Date
-
Frequency
-
Dividend Yield
Earnings
Most Recent Earnings
Last Earnings for Q1 2022
Above by $0.14
$0.94 +17.5%
0.8
0.88
Up 6%
Actual vs Estimates
XX
xxx
Upcoming Estimates Unavailable
-
-
-
--